pI: 7.7056 |
Length (AA): 113 |
MW (Da): 12585 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 113 | 1uiz (A) | 0 | 113 | 27.00 | 0 | 1 | 1.41 | -1.04 |
2 | 113 | 2gdg (A) | 1 | 113 | 19.00 | 0 | 0.91 | 1.36 | -1.24 |
1 | 113 | 3fwt (A) | 0 | 112 | 99.99 | 0 | 1 | 2.2258 | -1.33 |
2 | 58 | 1otf (A) | 2 | 58 | 18.00 | 0.011 | 0.17 | 0.684625 | -0.21 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_129767)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G01650 | tautomerase/MIF superfamily protein |
Arabidopsis thaliana | AT5G57170 | Tautomerase/MIF superfamily protein |
Brugia malayi | Bm1_28435 | Bm-MIF-1, identical |
Caenorhabditis elegans | CELE_Y56A3A.3 | Protein MIF-1 |
Entamoeba histolytica | EHI_092370 | macrophage migration inhibitory factor-like protein |
Giardia lamblia | GL50803_12091 | Macrophage migration inhibitory factor |
Homo sapiens | 4282 | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
Leishmania braziliensis | LbrM.33.2010 | macrophage migration inhibitory factor-like protein |
Leishmania donovani | LdBPK_331840.1 | macrophage migration inhibitory factor-like protein |
Leishmania donovani | LdBPK_331850.1 | macrophage migration inhibitory factor-like protein |
Leishmania infantum | LinJ.33.1850 | macrophage migration inhibitory factor-like protein |
Leishmania infantum | LinJ.33.1840 | macrophage migration inhibitory factor-like protein |
Leishmania major | LmjF.33.1750 | macrophage migration inhibitory factor-like protein |
Leishmania major | LmjF.33.1740 | macrophage migration inhibitory factor-like protein |
Leishmania mexicana | LmxM.32.1740 | macrophage migration inhibitory factor-like protein |
Leishmania mexicana | LmxM.32.1750 | macrophage migration inhibitory factor-like protein |
Loa Loa (eye worm) | LOAG_08159 | macrophage migration inhibitory factor |
Mus musculus | ENSMUSG00000033307 | macrophage migration inhibitory factor |
Neospora caninum | NCLIV_042400 | Macrophage migration inhibitory factor, related |
Oryza sativa | 4351273 | Os12g0107500 |
Oryza sativa | 4341957 | Os06g0699500 |
Oryza sativa | 4349563 | Os11g0107500 |
Plasmodium berghei | PBANKA_1444000 | macrophage migration inhibitory factor |
Plasmodium falciparum | PF3D7_1229400 | macrophage migration inhibitory factor |
Plasmodium knowlesi | PKNH_1448700 | macrophage migration inhibitory factor, putative |
Plasmodium vivax | PVX_124095 | macrophage migration inhibitory factor, putative |
Plasmodium yoelii | PY05452 | hypothetical protein |
Schmidtea mediterranea | mk4.000420.02 | Macrophage migration inhibitory factor |
Schmidtea mediterranea | mk4.000420.01 | Macrophage migration inhibitory factor |
Toxoplasma gondii | TGME49_290040 | macrophage migration inhibitory factor, putative |
Trichomonas vaginalis | TVAG_101850 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_219770 | macrophage migration inhibitory factor, mif, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_1444000 | Plasmodium berghei | Dispensable | plasmo |
TGME49_290040 | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Mus musculus | macrophage migration inhibitory factor | Compounds | References |
Homo sapiens | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Compounds | References |
Plasmodium falciparum | macrophage migration inhibitory factor | Compounds | References |